[SMC] Recognizing Symptoms of Congenital Myasthenic Syndromes in Children: A Guide for Paediatricians

[RSS-Bot]

Acta Paediatr. 2023 Aug 8. doi: 10.1111/apa.16945. Online ahead of print.

ABSTRACT

AIM: Congenital myasthenic syndromes (CMS) are a rare and diverse group of treatable neuromuscular transmission disorders. Diagnosis is often substantially delayed. This study aimed to identify common symptoms of CMS in children and their manifestation to aid diagnosis and early intervention.

METHODS: We performed a retrospective cohort study, including 18 children (median age 13 years, range 9;5-18;0 years) with CMS. Data on CMS symptoms and their manifestation were extracted from patients' charts and supplemented with parental telephone interviews. Descriptive analyses were used to identify common symptoms.

RESULTS: A median diagnostic delay of 4 years and 7 months (interquartile range: 51 months) was observed. Proximal muscle weakness (100%), ptosis (89%), clumsy gait (82%), difficulty eating solid foods (78%), and recurrent respiratory tract infections (72%) were most common in these patients. Symptoms mostly co-occurred and frequently had a fluctuating character, aggravated by infections or fatigue.

CONCLUSION: Early referral to diagnose CMS is crucial to enable timely initiation of treatment. Heightened attention to a combination of symptoms related to muscle weakness, rather than individual symptoms, should support paediatricians in flagging these neuromuscular disorders. Medical history taking should be tailored to parents' perceptions, asking questions about recognizable symptoms of muscle weakness.

PMID:37551152 | DOI:10.1111/apa.16945


Source: https://pubmed.ncbi.nlm.nih.gov/3755115 ... t6+86293ac